Philip Sturno serves as the Vice President of Global Research and Development at Bausch Health Companies, with a primary base in the New York City metropolitan area and professional operations linked to Morristown, New Jersey. His tenure at Bausch Health dates back to at least 2010, spanning the period post-split of Bausch & Lomb into Bausch Pharmaceuticals under the Bausch Health umbrella. Prior to and alongside this role, he has undertaken leadership responsibilities influencing both pharmaceutical and medical device sectors within the company.
Philip Sturno's career path includes critical roles such as Senior Director and Vice President of US Research and Development before advancing into his current global role. He also held a Director of Project Management position at Biovail Corporation, indicating broad project oversight experience in pharmaceutical R&D.
Within Bausch Health, Sturno has demonstrated a strong record of innovation leadership and strategic development execution. Notably, he has been instrumental in:
- Expanding product SKUs significantly, which contributed to measurable revenue growth across the company portfolio.
- Leading development activities that resulted in doubling of Dermatology over-the-counter (OTC) revenue, reflecting successful commercialization and market penetration strategies.
- Achieving direct report retention, implying effective talent management and leadership stability in key R&D teams.
His expertise encompasses pharmaceutical and biotechnology sectors, with a substantial focus on product development, process improvement, and cross-functional project management. This is underscored by advisory roles he holds with external entities including Padula Rehabilitation Therapies and participation in the Bain Advisor Network, suggesting recognized external industry insight and strategic influence.
Bausch Health Companies is a major global healthcare organization with a workforce exceeding 13,500 employees, operating in the eye health and pharmaceutical sectors through its subsidiaries such as Bausch Pharmaceuticals and Bausch & Lomb. The company’s portfolio includes research-driven development of healthcare products targeted at diverse therapeutic areas, emphasizing innovation and expansion of market presence—factors supported by Sturno’s leadership in research and development.
Philip Sturno’s location in New Jersey and involvement in high-level corporate R&D strategy positions him centrally within Bausch Health’s operational framework. His role in driving product diversification and revenue enhancement provides a strong indicator of his influence in the company’s growth trajectory and pipeline advancement.
Key Professional Details
- Current Title: Vice President, Global Research and Development, Bausch Health Companies
- Company: Bausch Health Companies Inc. (including Bausch Pharmaceuticals post Bausch & Lomb split)
- Location: Morristown, New Jersey, USA (primary)
- Experience: 14+ years with Bausch Health; prior senior project management at Biovail Corporation
- Core Contributions:
- Expanded product SKUs significantly
- Doubled Dermatology OTC revenue
- Maintained high direct report retention
- Additional Roles: Strategic Advisor for Padula Rehabilitation Therapies and Bain Advisor Network
This profile reflects Philip Sturno’s pivotal role in driving Bausch Health’s R&D innovation pipeline and commercial success, particularly through product portfolio expansion and revenue growth in dermatology and related therapeutic segments.
